FilingSEC EDGAR8-K
Aptevo Therapeutics to Present Multispecific Platform at SITC 2026
· SEC accepted
StageScheduled presentation
Filing content
Aptevo Therapeutics announced it will highlight its multispecific platform at the SITC 2026 Annual Meeting, scheduled for November 4–8, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…